GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.

Reddel HK.; FitzGerald JM.; Bateman ED.; Bacharier LB.; Becker A.; Brusselle G.; Buhl R.; Cruz AA.; Fleming L.; Inoue H.; Ko FW-S.; Krishnan JA.; Levy ML.; Lin J.; Pedersen SE.; Sheikh A.; Yorgancioglu A.; Boulet L-P.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.

Reddel HK., FitzGerald JM., Bateman ED., Bacharier LB., Becker A., Brusselle G., Buhl R., Cruz AA., Fleming L., Inoue H., Ko FW-S., Krishnan JA., Levy ML., Lin J., Pedersen SE., Sheikh A., Yorgancioglu A., Boulet L-P.

Original publication

DOI

10.1183/13993003.01046-2019

Type

Journal article

Journal

The European respiratory journal

Publication Date

06/2019

Volume

Addresses

Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia helen.reddel@sydney.edu.au.

Keywords

Humans, Asthma, Bronchodilator Agents, Anti-Asthmatic Agents, Monitoring, Physiologic, Administration, Inhalation, Adolescent, Adult, Disease Management, Randomized Controlled Trials as Topic, Practice Guidelines as Topic, Global Health